You are about to leave Risk Strategies website and view the content of an external website.
You are leaving risk-strategies.com
By accessing this link, you will be leaving Risk Strategies website and entering a website hosted by another party. Please be advised that you will no longer be subject to, or under the protection of, the privacy and security policies of Risk Strategies website. We encourage you to read and evaluate the privacy and security policies of the site you are entering, which may be different than those of Risk Strategies.
On December 23, 2022, federal agencies (the Departments of Labor, Health and Human Services, and the Treasury, collectively) released an FAQs document extending the reporting deadline for the Consolidated Appropriations Act, 2021 (CAA) prescription and healthcare spending data (referred to as RxDC reporting) from December 27, 2022, to January 31, 2023.
This deadline extension provides welcome relief for group health plans who have not yet submitted their RxDC reporting data to the Centers for Medicare & Medicaid Services (CMS), particularly those employers who must submit all or some of the RxDC reporting files directly to CMS on behalf of their group health plan. Note that many insurance carriers, third-party administrators (TPAs), and/or pharmacy benefit managers (PBMs), considered “reporting entities,” have already confirmed they submitted the RxDC reporting data on behalf of their group health plan clients.
Acknowledging the significant operational challenges that reporting entities have encountered in their compliance efforts with these new and complex reporting requirements, the agencies also confirmed in the FAQs they will not take enforcement action against any plans using a good faith, reasonable interpretation of the regulations and reporting instructions when submitting their RxDC reporting data to CMS.
The FAQs also contained several technical clarifications and flexibilities regarding the reporting requirements, including the following:
These technical clarifications primarily impact reporting entities, rather than employers sponsoring group health plans. However, those employers responsible for submitting their RxDC reporting directly to CMS are advised to take note of the items listed above.
Click here for a previous Risk Strategies article with background information and more details on RxDC reporting requirements.
This last-minute RxDC reporting deadline extension to January 31, 2023, will serve as a welcome respite for those group health plans who have yet to submit their RxDC reporting data to CMS.
Reach out to your Risk Strategies representative with any questions or contact us directly at firstname.lastname@example.org